Cherubism is a rare benign, autosomal-dominant hereditary fibro-osseous condition predominantly affecting the jaws. The gene for cherubism is src homology 3 binding protein 2 (SH3BP2) located on chromosome 4p16.3. Reinhard E Friedrich 1 , Hanna A Scheuer 2 , Jozef Zustin 3 , Tobias Grob 4 Affiliations 1 Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany rfriedrich@uke.de. Juliane Grobe Kopf- und Neurozentrum; Klinik und Poliklinik für Neurologie; Kontakt Telefon +49 (0) 40 7410 - 50117.
ELAVL1 is an RNA binding protein involved in translation control, which might have a regulatory role in prostate cancer progress.To evaluate its impact and relationship with key genomic alterations, ELAVL1 expression was analyzed by immunohistochemistry on a tissue microarray containing 12,427 prostate cancers.The analysis revealed a mild to moderate predominantly nuclear immunostaining in normal prostate epithelium and an often higher both cytoplasmic and nuclear expression in cancer cells. Search for more papers by this author ... of Pathology, Martinistraße 52, University Medical Center Hamburg‐Eppendorf, Hamburg, Germany. Forschungsgruppenleiter. Tobias Malte Ballhause Wissenschaftlicher Mitarbeiter Zentrum für Operative Medizin; Klinik und Poliklinik für Unfallchirurgie und Orthopädie ... SPENDENKONTO UKE gGmbH IBAN: DE54 2005 0550 1234 3636 36 Hamburger Sparkasse ONLINE-SPENDE WEITERE INFORMATIONEN . Unable to load your delegates due to an error Symmetrical cyst-like expansions of the jaws cause the characteristic facial swellings.
et phil.
Clipboard, Search History, and several other advanced features are temporarily unavailable. Please enable it to take advantage of the complete set of features! Institute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyMartini‐Clinic, Prostate Cancer Center, University Medical Center Hamburg‐Eppendorf, GermanyDepartment of Urology, Section for Translational Prostate Cancer Research, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyGeneral, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyMartini‐Clinic, Prostate Cancer Center, University Medical Center Hamburg‐Eppendorf, GermanyMartini‐Clinic, Prostate Cancer Center, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyGeneral, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyMartini‐Clinic, Prostate Cancer Center, University Medical Center Hamburg‐Eppendorf, GermanyInstitute of Pathology, University Medical Center Hamburg‐Eppendorf, GermanyCorrespondence to: Dr. Ronald Simon, Institute of Pathology, Martinistraße 52, University Medical Center Hamburg‐Eppendorf, Hamburg, Germany.
HighWire Please check your email for instructions on resetting your password. E‐mail: